Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00971048 · ClinicalTrials.gov registry record · NA

Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds

A NA study, sponsored by Healthpoint.

Completed
Registry status
NA
Development phase
88
Enrollment target

NCT00971048: Completed NA study, sponsored by Healthpoint.

NCT00971048 is a NA study that has completed, run by Healthpoint. The registered enrollment target is 88 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00971048, a NA study, has completed, sponsored by Healthpoint.

COMPLETED
Registry status
NA
Development phase
88 participants
Enrollment target

Study Summary

To compare HP828-101 to standard of care for the management of partial or full thickness wounds

Primary Outcome

Modified Bates-Jensen Wound Assessment (BWAT-m) Scores for those characteristics measured (wound size, depth, edges, undermining, necrotic tissue type and amount, exudate type and amount, periwound color and edema, granulation tissue, and epithelialization) were each graded on a 5-point scale, with 1 being the best and 5 being the worst.

Interventions

  • DEVICE HP828-101
  • DEVICE Hydrogel/Hydrocolloid

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2009-09
Est. Completion 2011-01
Phase NA
Healthpoint

25 total trials

What the finished NCT00971048 record still lists

NCT00971048 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which HP828-101 is the first listed.

NCT00971048 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00971048 about?

NCT00971048 is a clinical study titled "Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds". To compare HP828-101 to standard of care for the management of partial or full thickness wounds

What is the current status of trial NCT00971048?

This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2009-09. Estimated completion is 2011-01.

What interventions are being tested in trial NCT00971048?

The interventions under investigation include: HP828-101 (DEVICE), Hydrogel/Hydrocolloid (DEVICE).

Who is sponsoring clinical trial NCT00971048?

This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00971048's enrollment target sits among peer trials

88 972nd of 2000 higher than 1,027 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03843463 · 88 participants · Phase 2

    Escitalopram and Language Intervention for Subacute Aphasia

  • NCT04066348 · 88 participants · Phase 2

    TNF-α Treatment of Blast-Induced Tinnitus

  • NCT04331704 · 88 participants · Phase 4

    ANCHORS Alcohol & Sexual Health Study: UH3 Project

  • NCT04536103 · 88 participants

    Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00971048, the US trial registry maintained by the National Library of Medicine. NCT00971048 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.